IBDEI0PI ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12584,1,5,0)
 ;;=5^Thyroiditis, Acute
 ;;^UTILITY(U,$J,358.3,12584,2)
 ;;=^2692
 ;;^UTILITY(U,$J,358.3,12585,0)
 ;;=245.1^^87^820^44
 ;;^UTILITY(U,$J,358.3,12585,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12585,1,4,0)
 ;;=4^245.1
 ;;^UTILITY(U,$J,358.3,12585,1,5,0)
 ;;=5^Thyroiditis, Subacute
 ;;^UTILITY(U,$J,358.3,12585,2)
 ;;=^119376
 ;;^UTILITY(U,$J,358.3,12586,0)
 ;;=275.49^^87^820^41
 ;;^UTILITY(U,$J,358.3,12586,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12586,1,4,0)
 ;;=4^275.49
 ;;^UTILITY(U,$J,358.3,12586,1,5,0)
 ;;=5^Pseudohypoparathyroidism
 ;;^UTILITY(U,$J,358.3,12586,2)
 ;;=Pseudohypparathyroidism^317904
 ;;^UTILITY(U,$J,358.3,12587,0)
 ;;=266.2^^87^820^45
 ;;^UTILITY(U,$J,358.3,12587,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12587,1,4,0)
 ;;=4^266.2
 ;;^UTILITY(U,$J,358.3,12587,1,5,0)
 ;;=5^Vitamin B12 Deficiency
 ;;^UTILITY(U,$J,358.3,12587,2)
 ;;=Vitamin B12 Deficiency^87347
 ;;^UTILITY(U,$J,358.3,12588,0)
 ;;=268.9^^87^820^47
 ;;^UTILITY(U,$J,358.3,12588,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12588,1,4,0)
 ;;=4^268.9
 ;;^UTILITY(U,$J,358.3,12588,1,5,0)
 ;;=5^Vitamin D Deficiency
 ;;^UTILITY(U,$J,358.3,12588,2)
 ;;=Vitamin D Deficiency^126968
 ;;^UTILITY(U,$J,358.3,12589,0)
 ;;=266.1^^87^820^46
 ;;^UTILITY(U,$J,358.3,12589,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12589,1,4,0)
 ;;=4^266.1
 ;;^UTILITY(U,$J,358.3,12589,1,5,0)
 ;;=5^Vitamin B6 Deficiency
 ;;^UTILITY(U,$J,358.3,12589,2)
 ;;=^101683
 ;;^UTILITY(U,$J,358.3,12590,0)
 ;;=255.41^^87^820^1
 ;;^UTILITY(U,$J,358.3,12590,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12590,1,4,0)
 ;;=4^255.41
 ;;^UTILITY(U,$J,358.3,12590,1,5,0)
 ;;=5^Adrenal Insuff
 ;;^UTILITY(U,$J,358.3,12590,2)
 ;;=^335240
 ;;^UTILITY(U,$J,358.3,12591,0)
 ;;=277.6^^87^820^2
 ;;^UTILITY(U,$J,358.3,12591,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12591,1,4,0)
 ;;=4^277.6
 ;;^UTILITY(U,$J,358.3,12591,1,5,0)
 ;;=5^Alpha-1 Antitrypsin Deficiency
 ;;^UTILITY(U,$J,358.3,12591,2)
 ;;=^87463
 ;;^UTILITY(U,$J,358.3,12592,0)
 ;;=274.9^^87^820^14
 ;;^UTILITY(U,$J,358.3,12592,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12592,1,4,0)
 ;;=4^274.9
 ;;^UTILITY(U,$J,358.3,12592,1,5,0)
 ;;=5^Gout,Unspec
 ;;^UTILITY(U,$J,358.3,12592,2)
 ;;=^52625
 ;;^UTILITY(U,$J,358.3,12593,0)
 ;;=274.00^^87^820^15
 ;;^UTILITY(U,$J,358.3,12593,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12593,1,4,0)
 ;;=4^274.00
 ;;^UTILITY(U,$J,358.3,12593,1,5,0)
 ;;=5^Gouty Arthritis NOS
 ;;^UTILITY(U,$J,358.3,12593,2)
 ;;=^338313
 ;;^UTILITY(U,$J,358.3,12594,0)
 ;;=272.4^^87^820^22
 ;;^UTILITY(U,$J,358.3,12594,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12594,1,4,0)
 ;;=4^272.4
 ;;^UTILITY(U,$J,358.3,12594,1,5,0)
 ;;=5^Hyperlipidemia NEC/NOS
 ;;^UTILITY(U,$J,358.3,12594,2)
 ;;=^87281
 ;;^UTILITY(U,$J,358.3,12595,0)
 ;;=273.3^^87^820^37
 ;;^UTILITY(U,$J,358.3,12595,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12595,1,4,0)
 ;;=4^273.3
 ;;^UTILITY(U,$J,358.3,12595,1,5,0)
 ;;=5^Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,12595,2)
 ;;=^73013
 ;;^UTILITY(U,$J,358.3,12596,0)
 ;;=278.02^^87^820^40
 ;;^UTILITY(U,$J,358.3,12596,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12596,1,4,0)
 ;;=4^278.02
 ;;^UTILITY(U,$J,358.3,12596,1,5,0)
 ;;=5^Overweight
 ;;^UTILITY(U,$J,358.3,12596,2)
 ;;=^332745
 ;;^UTILITY(U,$J,358.3,12597,0)
 ;;=493.92^^87^821^4
 ;;^UTILITY(U,$J,358.3,12597,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12597,1,4,0)
 ;;=4^493.92
 ;;^UTILITY(U,$J,358.3,12597,1,5,0)
 ;;=5^Asthma, Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,12597,2)
 ;;=^322001
 ;;^UTILITY(U,$J,358.3,12598,0)
 ;;=493.20^^87^821^14
